Cite
HARVARD Citation
Cookson, T. et al. (n.d.). A142 INFLAMMATORY BOWEL DISEASE PATIENTS REQUIRE AN INCREASED ADALIMUMAB DRUG LEVEL TO SIMULTANEOUSLY ACHIEVE CLINICAL AND BIOLOGICAL REMISSION. Journal of the Canadian Association of Gastroenterology. pp. 282-283. [Online].